12-49026431-G-A
Variant summary
The NM_003482.4(KMT2D):c.15535C>T (p.Arg5179Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The gene KMT2D is a tumor suppressor gene (CancerMine: 29 TSG, 29 oncogene, 10 driver citations). The gene KMT2D is a known oncogene (CancerMine: 29 TSG, 29 oncogene, 10 driver citations). The gene KMT2D is a cancer driver gene (CancerMine: 29 TSG, 29 oncogene, 10 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 8.00). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R5179P: Likely_pathogenic (ClinVar VariationId 1513321, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R5179= (synonymous): Benign (ClinVar VariationId 2908675, 1 star) The variant position is a cancer hotspot (cancerhotspots.org): 10 samples carry this exact amino acid change out of 40 samples with a variant at this residue. The variant has been observed in cBioPortal in 17 samples across 15 studies and 12 cancer types; somatic enrichment level: SUPPORTING (Observed repeatedly in cBioPortal somatic datasets.). This exact variant is curated in the UniProt human variants database as Pathogenic, associated with Adenomas and Adenocarcinomas.
Frequency
Consequence
NM_003482.4 missense
Scores
Clinical Significance
Conservation
Publications
- choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Illumina, PanelApp Australia
- Kabuki syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine, ClinGen
- branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Kabuki syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Likely_pathogenic. The variant received 9 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O1Established oncogenic variant | TSG gene: ClinVar germline P/LP ★★+ — Moderate (O1); O1 contributing sources (2.0 pts): ClinVar germline P/LP in TSG (★★) | ||
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2]) | ||
| O4Enriched in somatic variant database | Enriched in cBioPortal (pre-computed score ≥ 1.0) — Supporting (O4); cBioPortal: samples=17 | studies=15 | cancer types=12 | level=SUPPORTING | points=1.0 | reason: Observed repeatedly in cBioPortal somatic datasets. | ||
| O5Same location/impact as known oncogenic | Different AA at same residue with oncogenic evidence (or germline P/LP in TSG), or same AA change SCI Tier II Potential — Supporting (O5); ClinVar same-AA oncogenic/T1: false | ClinVar same-AA SCI tier: — | CGI same-AA oncogenic: false | TSG: true | ClinVar same-AA germline P/LP: false | CIViC LOF: false | ClinVar diff-AA oncogenic: false | ClinVar diff-AA germline P/LP: true | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect | ||
| O7Mutational hotspot or critical domain | Moderate: ≥10 same AA change, or strong functional domain signal; Note: exclude MSK/TCGA-derived samples from cancerhotspots count to avoid double-counting with O4; cancerhotspots.org: total samples at AA position = 40, same AA change = 10; Exclude MSK/TCGA-derived samples from count to avoid double-counting with O4; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 1 pathogenic, 3 benign (OR vs. background: 2.1); Variant does not impact splicing — splice-hotspot path not applicable |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_003482.4. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
KMT2D | TSL:5MANE Select | c.15535C>T p.Arg5179Cys | missense | Exon 49 of 55 | Prot: ENSP00000301067.7 UniProt: | |
KMT2D | c.15535C>T p.Arg5179Cys | missense | Exon 49 of 56 | Prot: ENSP00000506726.1 UniProt: | ||
KMT2D | c.15544C>T p.Arg5182Cys | missense | Exon 48 of 54 | Prot: ENSP00000509386.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 4 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | Cov:33 | ||||
GnomAD4 genome | Cov:32 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00 | AC:0 | Hom:0 | AN:23446 | |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 30 | |
AlphaMissense | Pathogenic | 0.96 | |
BayesDel_addAF | Pathogenic | 0.28 | D |
BayesDel_noAF | Pathogenic | 0.16 | |
CADD | Pathogenic | 28 | |
DANN | Uncertain | 0.98 | |
DEOGEN2 | Benign | 0.28 | T |
Eigen | Pathogenic | 0.91 | |
Eigen_PC | Pathogenic | 0.85 | |
FATHMM_MKL | Uncertain | 0.96 | D |
FuncVEP CTI | Pathogenic | 0.99 | |
GPN-Star LLR | N/A | -10 | |
GPN-Star score | N/A | 10 | |
LIST_S2 | Pathogenic | 0.99 | D |
M_CAP | Pathogenic | 0.65 | D |
MetaRNN | Pathogenic | 0.92 | D |
MetaSVM | Uncertain | 0.60 | D |
Mutation Taster | N/A | 12/88 | disease causing (ClinVar) |
MutationAssessor | Pathogenic | 3.2 | M |
PhyloP100 | Pathogenic | 8.0 | |
PrimateAI | Pathogenic | 0.85 | D |
PromoterAI | N/A | -0.0020 | Neutral |
PROVEAN | Pathogenic | -7.7 | D |
RBP_binding_hub_radar | N/A | 0.92 | |
RBP_regulation_power_radar | N/A | 2.7 | |
REVEL | Pathogenic | 0.91 | |
Sift | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.76 | |
VESM-3B | Benign | -9.1 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.